The Valley Desk

ArticleJournal of neuro-oncologyPublished

Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Article
Venue
Journal of neuro-oncology
Published
Subject terms
Cell Line, Tumor; Humans; Glioblastoma; Brain Neoplasms; DNA Repair Enzymes; DNA Modification Methylases; Tumor Suppressor Proteins; Antineoplastic Agents, Alkylating; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Drug Resistance, Neoplasm
PubMed ID
38762829
Added to directory
Source checked

Report a correction or request removal